
| 4 min read
Without standardized, strain-level analysis, and clinically meaningful benchmarks, microbiome science will struggle to move from research into routine care.
| 4 min read
As the FDA shifts toward nonclinical methods, scientists weigh whether alternative technologies can match the predictive power of animal studies.
| 9 min read
Industry leaders predict this year will be shaped by AI-driven discovery, human-relevant safety testing, and tighter capital discipline.
| 3 min read
By combining human-derived data with AI-driven discovery, the partnership seeks to tackle Parkinson’s disease heterogeneity and improve target selection.News
Cancer Research News
The FDA’s National Priority Voucher program aims to cut standard review times from potentially years to months, raising questions about safety, access, and public health impact.
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures.
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Learn the fundamental weighing principles and operational controls that support reliable sample preparation.
Can animal testing be replaced? Discover how scientists are developing more human-relevant ways to predict drug toxicity earlier.



















